Explore Multiple Sclerosis, Form Of, and more!

@MSNewsToday - Autologous hematopoietic cell transplantation may be effective in highly active forms of MS #ECTRIMS2015 #MSNewsToday

- Autologous hematopoietic cell transplantation may be effective in highly active forms of MS

It is Multiple Sclerosis Awareness Week. Educate your self on the symptoms of MS. http://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms @National MS Society #MSConnection

FDA Approves Plegridy (Pegylated Interferon Beta) For Relapsing MS : National Multiple Sclerosis Society

At ‪#‎ECTRIMS2015‬, a group of researchers concluded that HERV (human endogenous retroviruses) expression does appear to be greater in people with MS compared to those without ‪#‎MS‬, and viruses may well play a role in the MS disease process. Read more - http://msology.ca/aliens-inside-us-revisiting-the-viral-theory-of-multiple-sclerosis-ectrims-2015

Aliens inside us – Revisiting the viral theory of multiple sclerosis

At ‪#‎ECTRIMS2015‬, a group of researchers concluded that HERV (human endogenous retroviruses) expression does appear to be greater in people with MS compared to those without ‪#‎MS‬, and viruses may well play a role in the MS disease process. Read more - http://msology.ca/aliens-inside-us-revisiting-the-viral-theory-of-multiple-sclerosis-ectrims-2015

Medscape Medical News from the      Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2015  Medscape Medical News > Conference News First Data From Ocrelizumab Phase 3 Studies in MS  Sue Hughes October 08, 2015  http://www.medscape.com/viewarticle/852408?src=wnl_edit_tpal

Medscape Medical News from the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2015 Medscape Medical News > Conference News First Data From Ocrelizumab Phase 3 Studies in MS Sue Hughes October 08, 2015 http://www.medscape.com/viewarticle/852408?src=wnl_edit_tpal

Does vitamin D play a role in multiple sclerosis?

Does vitamin D play a role in multiple sclerosis

Tweeted by @SKriegerMD - "This is #ECTRIMS2015, every single person here to advance science & care for people #MultipleSclerosis. @SinaiBrain " #MSNewsToday

stephen krieger on

“This is every single person here to advance science & care for people

Coffee Drinking may confer the side-benefit of lowering the risk of developing multiple sclerosis (MS) in susceptible individuals, according to a meta-analysis of Swedish and American studies to be presented at the American Academy of Neurology’s 67th Annual Meeting to be held April 18-25, 2015 at the Walter E. Washington Convention Center in Washington, DC, and pre-released this week.  Previous research on potential associations between caffeine consumption and MS risk had been…

Caffeine In Coffee Found To Reduce Multiple Sclerosis Risk

Read how Allegheny General Hospital Offers New Treatment for Relapsing Multiple Sclerosis

Three oral medications are now available to treat multiple sclerosis, Aubagio, Tecfidera and Gilenya, and numerous researchers have examined their effectiveness and safety. ‪#‎MS‬ Here is a summary of some of the studies presented at ‪#‎ECTRIMS2015‬ - http://msology.ca/new-information-on-oral-therapies-for-multiple-sclerosis

New information on oral therapies for multiple sclerosis

Woman taking pills. Depressed young woman taking a pill while standing against grey background

Mike Nace, Editor-in-Chief of Multiple Sclerosis News Today, Reviews Day 2-3 at #ECTRIMS2015

Mike Nace, Editor-in-Chief of Multiple Sclerosis News Today, Reviews Day 2-3 at #ECTRIMS2015

Multiple Sclerosis, News Today, Mike D'antoni, Editor

<span class="entry-title">Prof. Jorge Correale Reviews Environmental Factors Associated with Multiple Sclerosis at ECTRIMS 2015</span><span class="entry-subtitle">Environmental Factors Linked to MS</span>

Prof. Jorge Correale Reviews Environmental Factors Associated with Multiple Sclerosis at ECTRIMS 2015

Toll-Free Helpline    A toll-free Helpline allows individuals with MS, family members, care partners, and friends, to speak directly with one of MSAA's experienced consultants who have a social services or counseling background.    MSAA's Helpline may be reached by calling: (800) 532-7667, extension 154 Monday through Friday, 8:30 am to 5:00 pm, eastern time or by emailing MSquestions@mymsaa.org.

Volunteer with Multiple Sclerosis Association of America (MSAA). Find Multiple Sclerosis Association of America (MSAA) volunteering opportunities at VolunteerMatch!

Women have a 2-3 fold higher risk of developing multiple sclerosis compared to men, which suggests that hormones influence the development of the disease.  A number of studies at this year’s ECTRIMS meeting examined different aspects of this ‪#‎MS‬-hormone connection, such as puberty, fertility and pregnancy. Read more about the findings: http://msology.ca/multiple-sclerosis-and-womens-health

Multiple sclerosis and women’s health

Women have a 2-3 fold higher risk of developing multiple sclerosis compared to men, which suggests that hormones influence the development of the disease. A number of studies at this year’s ECTRIMS meeting examined different aspects of this ‪#‎MS‬-hormone connection, such as puberty, fertility and pregnancy. Read more about the findings: http://msology.ca/multiple-sclerosis-and-womens-health

Biogen to Present Update on TECFIDERA (Dimethyl Fumarate) for Early Stage Relapsing-Remitting Multiple Sclerosis at ECTRIMS 2015

Biogen to Present Update on TECFIDERA (Dimethyl Fumarate) for Early Stage Relapsing-Remitting Multiple Sclerosis at ECTRIMS 2015

Read more about Biogen presentation on TECFIDERA (dimethyl fumarate) for early stage relapsing-remitting multiple sclerosis at ECTRIMS

Large Multiple Sclerosis Product Update To Be Presented By Biogen

Large Multiple Sclerosis Product Update To Be Presented By Biogen

Low Dose Naltrexone May Improve Multiple Sclerosis Patient Quality of Life

Read more about Lemtrada as a potential alternative therapy for patients with relapsing remitting multiple sclerosis – a 5-year Phase III clinical trial.

Genzyme Provides Update on Lemtrada for Patients with Relapsing-Remitting Multiple Sclerosis

Read more about Lemtrada as a potential alternative therapy for patients with relapsing remitting multiple sclerosis – a Phase III clinical trial.

ECTRIMS Highlights Latest Developments in Multiple Sclerosis Research

ECTRIMS Highlights Latest Developments in Multiple Sclerosis Research

This Isn’t How a Democracy Should Work: How the Media Boosted Donald Trump and Screwed Bernie Sanders

Pinterest
Search